news
03-26-2012, 10:02 PM
Appellate judges were told to reconsider a ruling that let Myriad Genetics patent two genes that confer a high risk of breast and ovarian cancer.
http://ads.pheedo.com/img.phdo?p=1 (http://ads.pheedo.com/click.phdo?p=1)
More... (http://feeds.nytimes.com/click.phdo?i=810490b31fed494f55edcf41fb0203d9)
http://ads.pheedo.com/img.phdo?p=1 (http://ads.pheedo.com/click.phdo?p=1)
More... (http://feeds.nytimes.com/click.phdo?i=810490b31fed494f55edcf41fb0203d9)